Comparison of 131I- and 90Y-labeled monoclonal antibody 17-1A for treatment of human colon cancer xenografts
- 1 March 1993
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 25 (4) , 629-638
- https://doi.org/10.1016/0360-3016(93)90009-k
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Three-dimensional tumor dosimetry for radioimmunotherapy using serial autoradiographyInternational Journal of Radiation Oncology*Biology*Physics, 1992
- The effect of antibody protein dose on the uniformity of tumor distribution of radioantibodies: An autoradiographic studyCancer Immunology, Immunotherapy, 1991
- Phase I-II studies of yttrium-labeled antiferritin treatment for end-stage Hodgkin's disease, including Radiation Therapy Oncology Group 87-01.Journal of Clinical Oncology, 1991
- Selection of a dtpa chelate conjugate for monoclonal antibody targeting to a human colonic tumor in nude miceInternational Journal of Cancer, 1990
- Advantage of Dose Fractionation in Monoclonal Antibody-Targeted RadioimmunotherapyJNCI Journal of the National Cancer Institute, 1990
- A comparison of 131I-labeled monoclonal antibody 17-1A treatment to external beam irradiation on the growth of LS174T human colon carcinoma xenograftsInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Dosimetry and treatment planning for 90Y-labelled antiferritin in hepatomaInternational Journal of Radiation Oncology*Biology*Physics, 1988
- Synthesis of 1-(p-isothiocyanatobenzyl) derivatives of DTPA and EDTA. Antibody labeling and tumor-imaging studiesInorganic Chemistry, 1986
- Radiolabeling of monoclonal antibody against carcinoembryonic antigen with 88Y and biodistribution studiesInternational Journal of Nuclear Medicine and Biology, 1985
- Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycolurilBiochemical and Biophysical Research Communications, 1978